Chinese biopharma Hutchmed today announced that the supplemental New Drug Application for Orpathys (savolitinib) has been ...

Dyno Therapeutics, a privately-held US genetic technologies company applying AI to enable in vivo gene delivery, has ...

French independent pharma company Servier says it has appointed David Lee to its executive committee as executive vice ...

Shares of USA-based Intra-Cellular Therapies leapt almost 36% to $128.85 in pre-marker activity today, as rumors of a ...

CNX Therapeutics partners with Klaria Pharma to market sumatriptan alginate film in Europe, addressing critical migraine ...

Medicines Discovery Catapult (MDC), the UK government-backed life sciences service dedicated to driving productivity and ...

US radiopharmaceuticals-focused Lantheus Holdings today announced a definitive agreement to acquire Life Molecular Imaging.

US fibrosis-focused drug developer Mediar Therapeutics has entered into global licensing agreement with US pharma major Eli ...

California-based immunology start-up Ouro Medicines, which is developing immune reset therapeutics for people living with ...

Aragen Life Sciences secures $100M investment from Quadria Capital, valuing the CRDMO at $1.4B. The funding supports ...

China's top drug regulator has recently approved the nation's first stem cell therapy to treat a type of complication ...

Teva partners with Klinge Biopharma and Formycon to commercialize FYB203, an Eylea biosimilar, as Ahzantive in Europe and ...